ADC Therapeutics SA
NYSE:ADCT
ADC Therapeutics SA
NYSE:ADCT
Price:
4.22
USD
2.18%
Market Cap:
$522.8m
Balance Sheet
Balance Sheet Decomposition
ADC Therapeutics SA
ADC Therapeutics SA
Balance Sheet Decomposition is not available for
ADC Therapeutics SA
ADC Therapeutics SA
Balance Sheet
ADC Therapeutics SA
ADC Therapeutics SA
Currency: USD
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
263
|
139
|
116
|
439
|
467
|
326
|
279
|
251
|
261
|
|
| Cash Equivalents |
263
|
139
|
116
|
439
|
467
|
326
|
279
|
251
|
261
|
|
| Total Receivables |
2
|
2
|
1
|
1
|
31
|
74
|
25
|
20
|
29
|
|
| Accounts Receivables |
1
|
0
|
0
|
0
|
30
|
73
|
25
|
20
|
29
|
|
| Other Receivables |
1
|
2
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
11
|
19
|
16
|
18
|
4
|
|
| Other Current Assets |
1
|
2
|
6
|
10
|
17
|
27
|
16
|
18
|
12
|
|
| Total Current Assets |
265
|
142
|
123
|
451
|
525
|
446
|
336
|
307
|
306
|
|
| PP&E Net |
1
|
2
|
6
|
5
|
11
|
10
|
16
|
13
|
1
|
|
| PP&E Gross |
1
|
2
|
6
|
5
|
11
|
10
|
16
|
13
|
1
|
|
| Accumulated Depreciation |
1
|
1
|
3
|
4
|
4
|
3
|
4
|
5
|
1
|
|
| Intangible Assets |
5
|
7
|
8
|
10
|
14
|
14
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
48
|
41
|
31
|
2
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
27
|
28
|
1
|
1
|
16
|
|
| Total Assets |
272
N/A
|
151
-45%
|
138
-9%
|
514
+273%
|
618
+20%
|
529
-14%
|
355
-33%
|
322
-9%
|
323
+0%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
8
|
7
|
3
|
5
|
12
|
12
|
16
|
18
|
9
|
|
| Accrued Liabilities |
4
|
5
|
6
|
12
|
16
|
16
|
39
|
51
|
44
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
1
|
5
|
8
|
14
|
1
|
0
|
3
|
|
| Other Current Liabilities |
9
|
11
|
10
|
19
|
38
|
57
|
13
|
11
|
14
|
|
| Total Current Liabilities |
21
|
22
|
20
|
40
|
74
|
99
|
68
|
80
|
70
|
|
| Long-Term Debt |
0
|
0
|
4
|
37
|
313
|
316
|
416
|
434
|
435
|
|
| Other Liabilities |
2
|
2
|
3
|
101
|
65
|
25
|
19
|
10
|
4
|
|
| Total Liabilities |
23
N/A
|
24
+7%
|
27
+9%
|
178
+572%
|
452
+154%
|
440
-3%
|
503
+14%
|
525
+4%
|
509
-3%
|
|
| Equity | ||||||||||
| Common Stock |
0
|
0
|
4
|
6
|
6
|
7
|
7
|
8
|
11
|
|
| Retained Earnings |
204
|
326
|
443
|
652
|
822
|
925
|
1 335
|
1 493
|
1 636
|
|
| Additional Paid In Capital |
452
|
452
|
550
|
981
|
982
|
1 008
|
1 181
|
1 284
|
1 440
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Total Equity |
249
N/A
|
126
-49%
|
111
-12%
|
336
+202%
|
166
-50%
|
89
-47%
|
148
N/A
|
203
-37%
|
186
+8%
|
|
| Total Liabilities & Equity |
272
N/A
|
151
-45%
|
138
-9%
|
514
+273%
|
618
+20%
|
529
-14%
|
355
-33%
|
322
-9%
|
323
+0%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
77
|
77
|
77
|
77
|
77
|
81
|
82
|
99
|
126
|
|
Switch to:
Switch to:
See Also
Discover More
